Venous thromboembolism risk and erythropoiesis-stimulating agents for the treatment of cancer-associated anemia: a meta-analysis
出版年份 2013 全文链接
标题
Venous thromboembolism risk and erythropoiesis-stimulating agents for the treatment of cancer-associated anemia: a meta-analysis
作者
关键词
Venous thromboembolism, Erythropoiesis-stimulating agents, Erythropoietin, Darbepoetin, Anemia, Cancer, Meta-analysis
出版物
TUMOR BIOLOGY
Volume 35, Issue 1, Pages 603-613
出版商
Springer Nature
发表日期
2013-08-19
DOI
10.1007/s13277-013-1084-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel, and CMF versus a standard-dosed epirubicin–cyclophosphamide followed by paclitaxel with or without darbepoetin alfa in primary breast cancer—outcome on prognosis
- (2011) M. Untch et al. ANNALS OF ONCOLOGY
- Randomised, phase III trial of epoetin-β to treat chemotherapy-induced anaemia according to the EU regulation
- (2011) Y Fujisaka et al. BRITISH JOURNAL OF CANCER
- Epoetin alpha decreases the number of erythrocyte transfusions in patients with acute lymphoblastic leukemia, lymphoblastic lymphoma, and Burkitt leukemia/lymphoma
- (2011) Maria E. Cabanillas et al. CANCER
- Randomized Phase III Trial of Sequential Adjuvant Chemoradiotherapy With or Without Erythropoietin Alfa in Patients With High-Risk Cervical Cancer: Results of the NOGGO-AGO Intergroup Study
- (2011) Jens-Uwe Blohmer et al. JOURNAL OF CLINICAL ONCOLOGY
- Role of recombinant human erythropoietin in patients of advanced cervical cancer treated by chemoradiotherapy
- (2010) Seema Gupta et al. CANCER BIOLOGY & THERAPY
- Epoetin Alfa Improves Anemia and Anemia-Related, Patient-Reported Outcomes in Patients with Breast Cancer Receiving Myelotoxic Chemotherapy: Results of a European, Multicenter, Randomized, Controlled Trial
- (2010) P. Pronzato et al. ONCOLOGIST
- A risk model for severe anemia to select cancer patients for primary prophylaxis with epoetin : a prospective randomized controlled trial of the ELYPSE study group
- (2009) I. Ray-Coquard et al. ANNALS OF ONCOLOGY
- Randomized, double-blind, placebo-controlled trial of every-3-week darbepoetin alfa 300 micrograms for treatment of chemotherapy-induced anemia
- (2009) Enrique Hernandez et al. CURRENT MEDICAL RESEARCH AND OPINION
- Weekly Administration of Epoetin Beta for Chemotherapy-induced Anemia in Cancer Patients: Results of a Multicenter, Phase III, Randomized, Double-blind, Placebo-controlled Study
- (2009) Masahiro Tsuboi et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Effect of Epoetin Alfa on Survival and Cancer Treatment–Related Anemia and Fatigue in Patients Receiving Radical Radiotherapy With Curative Intent for Head and Neck Cancer
- (2009) Peter J. Hoskin et al. JOURNAL OF CLINICAL ONCOLOGY
- HX575, Recombinant Human Epoetin Alfa, for the Treatment of Chemotherapy-Associated Symptomatic Anaemia in Patients with Solid Tumours
- (2009) Karin Weigang-Köhler et al. Oncology Research and Treatment
- Venous Thromboembolism and Mortality Associated With Recombinant Erythropoietin and Darbepoetin Administration for the Treatment of Cancer-Associated Anemia
- (2008) Charles L. Bennett JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Once-Weekly Epoetin Beta on Survival in Patients With Metastatic Breast Cancer Receiving Anthracycline- and/or Taxane-Based Chemotherapy: Results of the Breast Cancer—Anemia and the Value of Erythropoietin (BRAVE) Study
- (2008) Matti Aapro et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and Efficacy of Darbepoetin Alfa in Previously Untreated Extensive-Stage Small-Cell Lung Cancer Treated With Platinum Plus Etoposide
- (2008) Robert Pirker et al. JOURNAL OF CLINICAL ONCOLOGY
- ESAs Further Restricted, but Debate Continues
- (2008) V. Brower JNCI-Journal of the National Cancer Institute
- A Systematic Review and Meta-Analysis of the Pharmacological Treatment of Cancer-Related Fatigue
- (2008) O. Minton et al. JNCI-Journal of the National Cancer Institute
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now